Patient-related barriers represent about 30% of therapeutic inertia such as misconceptions regarding insulin risk, injection phobia, fear of weight gain, fear of hypoglycemia, negative impact on social life and job, poor health literacy, low self-efficacy and healthcare providers’ inadequacy [7,8]. This evidence concerns the gene INS and Hypoglycemia.